tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MEDP Stock Latest News

Palantir upgraded, Workday downgraded: Wall Street’s top analyst calls
The FlyPalantir upgraded, Workday downgraded: Wall Street’s top analyst calls
5d ago
DHR
GPC
Medpace upgraded to Hold from Sell at TD Cowen
PremiumThe Fly
Medpace upgraded to Hold from Sell at TD Cowen
5d ago
MEDP
Medpace upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Medpace upgraded to Buy from Hold at Jefferies
10d ago
MEDP
Medpace price target lowered to $539 from $555 at Truist
PremiumThe Fly
Medpace price target lowered to $539 from $555 at Truist
12d ago
MEDP
Medpace price target lowered to $460 from $600 at BMO Capital
PremiumThe Fly
Medpace price target lowered to $460 from $600 at BMO Capital
12d ago
MEDP
Medpace Holdings’ Earnings Call Signals Growth Amid Volatility
PremiumCompany AnnouncementsMedpace Holdings’ Earnings Call Signals Growth Amid Volatility
12d ago
MEDP
Baird upgrades Medpace to Outperform on earnings selloff
Premium
The Fly
Baird upgrades Medpace to Outperform on earnings selloff
12d ago
MEDP
Medpace upgraded to Outperform from Neutral at Baird
Premium
The Fly
Medpace upgraded to Outperform from Neutral at Baird
13d ago
MEDP
Medpace falls -14.7%
PremiumThe Fly
Medpace falls -14.7%
13d ago
MEDP
CRO peers lower after Medpace earnings, comments on cancellations
PremiumThe Fly
CRO peers lower after Medpace earnings, comments on cancellations
13d ago
CRL
FTRE
Medpace says cancellations ‘widespread’ in Q4
PremiumThe Fly
Medpace says cancellations ‘widespread’ in Q4
13d ago
MEDP
Closing Bell Movers: Upwork down over 20% on soft guidance
PremiumThe Fly
Closing Bell Movers: Upwork down over 20% on soft guidance
13d ago
GT
ON
Medpace reports Q4 EPS $4.67, consensus $4.23
PremiumThe FlyMedpace reports Q4 EPS $4.67, consensus $4.23
13d ago
MEDP
Medpace sees FY26 EPS $16.68-$17.50, consensus $16.51
Premium
The Fly
Medpace sees FY26 EPS $16.68-$17.50, consensus $16.51
13d ago
MEDP
MEDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MEDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
16d ago
MEDP
Medpace price target raised to $660 from $655 at Mizuho
PremiumThe Fly
Medpace price target raised to $660 from $655 at Mizuho
1M ago
MEDP
Medpace price target raised to $525 from $485 at Barclays
PremiumThe Fly
Medpace price target raised to $525 from $485 at Barclays
2M ago
MEDP
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
PremiumThe Fly
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
3M ago
IQV
FTRE
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
3M ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe FlyFDA to reduce number of trials required for drug approvals, STAT reports
3M ago
AZN
BMY
Medpace initiated with a Market Perform at BMO Capital
Premium
The Fly
Medpace initiated with a Market Perform at BMO Capital
3M ago
MEDP
Medpace Holdings Inc: Key Update on the OPAL Study for Lymphoid Malignancies
Premium
Company Announcements
Medpace Holdings Inc: Key Update on the OPAL Study for Lymphoid Malignancies
4M ago
MEDP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >